StockWatch
·
SHRIRAM PISTONS & RINGS LTD · QQ2 FY-2027 · THE CALL

Strong growth offset by margin compression; recovery expected next quarter

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsSHRIPISTONShriram Pistons & Rings Ltd06 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Hit implicit topline growth guidance, accurately explained margin compression via commodity lag and mix, acknowledged Antolin finance cost headwind (₹234M Q2). Evasive on capex numbers and order win details (competitive sensitivity).

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong 62% YoY revenue growth and order visibility (₹1,000+ Cr new pipeline) support long-term narrative. However, Q2 delivered margin compression (standalone EBITDA 19.9% vs prior 21%, gross margin 55%-56% vs ~60%) on commodity lag and mix shift, with recovery contingent on Q3 pass-through. Management tone cautious on capex specifics and forward guidance, signaling execution risk. Hold pending Q3 margin recovery validation and clearer forward quantification.

₹1648.2 Cr

Revenue · +62.1% YoY

₹162.3 Cr

Reported PAT · +14.2% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Q2 consolidated revenue grew 61% YoY to ₹1674.6Cr

MET

Delivered revenue ₹1648.2 Cr (62.1% YoY growth)

EBITDA margin 17.9% for Q2

MET

Calculated margin ₹300.4 Cr / ₹1648.2 Cr = 18.2%

PBT excluding Antolin finance costs grew 23% in Q2

MET

Reported PAT 14.2% YoY; finance costs ₹234M in Q2 depress PAT

Standalone business grew 17% YoY

MET

Standalone revenue ₹10,500M stated vs market data alignment

Gross margins compressed from ~60% to 55%-56%

MET

Margin compression evident in stated cost pressures and mix changes

Earnings quality

What changed since the last call

Deltas vs. the prior call

Mix-driven margin reset

Downgrade

Gross margins fell from ~60% pre-call baseline to 55%-56% as volume surge forced product mix shift. Standalone EBITDA margin fell from 21% to 19.9%.

Antolin integration status

Neutral

On track operationally and financially. Finance costs ₹234M Q2 depressing consolidated PAT, but management reaffirms temporary nature and integration synergy capture.

Capex outlook

Neutral

Management refuses numeric capex guidance, says 'keeps changing with every discussion.' No shift from prior call, same hedge position.

Long-term portfolio positioning

Neutral

Reaffirmed >35% powertrain agnostic revenue, ~60% business insulated from powertrain shifts. New order pipeline ₹1,000+ Cr visible. No change from prior narrative.

The Q&A

Analysts pressed hard on gross margin recovery timeline, capex numbers, and order win details. Management held firm on not quantifying capex ('misleading if we do') and order wins ('competitive sensitivity'). Candid on commodity lag mechanics and wage cost impact, but defensive overall.

The exchanges that mattered

Capex plans — Vivek, DSP Mutual Fund

Dodged

Capex expanding in Pithampur, Pathredi, Ghaziabad, Neemrana precision molding, TGPEL, interiors. Size 'very sizable' but no numbers given; keeps changing with decisions.

Headliner adoption — Radha, Motilal Oswal

Answered

Small cars 15%-18% cost improvement, bigger vehicles up to 30%-40%. Nominated by customers for EV programs. Two-three customers in proof-of-concept phase.

Piston growth sustainability — Radha, Motilal Oswal

Answered

Yes, maintained 17% H1 standalone growth. Market growing 7%-8%, we outgrowing. Next 2 years taper to 7%-8% CAGR as base normalizes.

Incremental growth source — Ravi Purohit, Securities Investment Management

Answered

New order wins between ₹1,000 crores easil above existing ₹6,000 crores business. Lighting, Antolin complete assembly wins, non-auto. Growth could be 9%-14% depending on mix.

Gross margin decline attribution — Harsh Shah, Seven Rivers Holdings

Partial

Complex: mix 4%-5% impact, time lag ~1 quarter. Recovery formula depends on customer, varies. Whole recovery based on respective raw material.

Standalone EBITDA normalization — Harsh Shah, Seven Rivers Holdings

Answered

No. Core EBITDA margin 19.9% in Q2, almost 20%, best in industry. 1%-2% drop from mix, most costs getting covered, can improve costs.

Defense/aerospace adjacency — Harsh Shah, HRS Enterprises

Answered

Defense good possibility (Shaktiman, Avadi). Aerospace long gestation (3-5 years), requires NadCap, tests. Focused on defense Army applications, already supply multiple defense products.

Acquisition targets — Harsh Shah, HRS Enterprises

Partial

Clarified thermal mgmt was media misquote. Looking at parallel adjacencies specific to vehicle industry. Not direct entry into these, but adjacent areas.

Lighting revenue contribution — Vijay Pandey, Axis Capital

Answered

Growing at very good rate. Won excellent new programs. At acquisition ~20% of interiors business, growing much faster than interiors now.

RM basket composition Q3 — Vijay Pandey, Axis Capital

Partial

Very difficult to quantify, month-to-month variations. Depends on sales mix. Aluminum ~50%, steel/copper ~20%-25%. All depends on kind of mix and supplies.

Guidance

Forward guidance and management's confidence

Grow with market 7%-8% as base normalizes post-FY27

Medium

FY27 is high-growth year due to Antolin acquisition, volume ramp, new wins. Thereafter normalize to market CAGR. Piston segment ~10%-12% for 2-3 years, then 7%-8% CAGR.

Margin normalization expected Q3 FY27

Medium

Commodity pass-through lag to unwind as Q3 covers commodity inflation spike. Gross margins expected to improve from 55%-56% back toward 58%-60%. Standalone EBITDA margin target ~20% (vs 19.9% Q2).

Antolin to reach mid-teens EBITDA margins long-term

Medium

Currently depressed due to finance costs ₹234M Q2 from acquisition debt. Post-debt repayment, margins to normalize toward 15%+ as scale benefits accrue.

Capex ongoing across all segments, size 'very sizable'

Low

Management deliberately avoids quantifying, says capex plan changes with every strategic decision. Backed by firm orders. Most expansions phased (Pithampur, Pathredi, Ghaziabad, Neemrana).

Risks the call surfaced

Ranked by how much they should concern a holder

Commodity & geopolitical

High

1-quarter pass-through lag leaves gross margins compressed 400+ bps. Oil, tools, dyes elevated due to Russia-Ukraine and Middle East tensions. Recovery dependent on supply chain normalization.

Margin volatility

High

Operating at 75%-80% capacity. Market volume surge to 30%-35% forced product mix shift to preserve market share, compressing gross margins 400+ bps. Q3 recovery dependent on commodity lag pass-through, not mix normalization.

Wage cost & regulation

Medium

Minimum Wages Act revisions in Haryana, UP, Rajasthan. PF and gratuity regulation changes creating new cost floor. Large workforce makes this a 'sizable amount' impact.

Antolin integration & finance cost

Medium

Finance costs ₹234M Q2, ₹486M H1 from Antolin acquisition debt financing. Temporary but material drag on consolidated PAT. Integration execution risk remains.

Customer concentration & order detail risk

Medium

Management refuses to name customers or detail order wins, citing competitive sensitivity. Suggests concentration risk and limits transparency.

Capex execution & guidance

Medium

Management refuses to quantify capex, says 'keeps changing with every discussion.' Suggests execution uncertainty and strategic flexibility, but also raises visibility risk.

Management

Score 6/10. Candid on challenges (commodity lag, wage pressures, integration costs) and detailed on business mechanics (mix impact, pass-through lag). Evasive on capex numbers and order win specifics, citing competitive sensitivity. Hit topline growth targets (~62% YoY vs 61% claimed). Accurately explained margin compression via commodity lag and mix shift. Antolin integration on track operationally. Track record credible on acknowledged headwinds.

What to watch next
  • 1 · Q3 FY27

    Commodity pass-through lag unwinds, margin normalization expected

  • 2 · Apr 2027

    Precision plastics ABS product supplies begin for 2-wheeler regulators

  • 3 · FY28

    EMFI and Takahata capacity expansions begin revenue contribution

Hold pending Q3 margin recovery validation and clearer forward quantification.

Informational and educational content only. Not investment advice.